1. Home
  2. NGNE vs SHIP Comparison

NGNE vs SHIP Comparison

Compare NGNE & SHIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$27.00

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Logo Seanergy Maritime Holdings Corp.

SHIP

Seanergy Maritime Holdings Corp.

HOLD

Current Price

$13.98

Market Cap

318.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGNE
SHIP
Founded
2003
2008
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
327.8M
318.3M
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
NGNE
SHIP
Price
$27.00
$13.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$63.57
$17.00
AVG Volume (30 Days)
138.7K
180.0K
Earning Date
05-08-2026
05-26-2026
Dividend Yield
N/A
3.04%
EPS Growth
0.93
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.07
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.34
Revenue Growth
N/A
N/A
52 Week Low
$11.78
$5.37
52 Week High
$37.27
$15.19

Technical Indicators

Market Signals
Indicator
NGNE
SHIP
Relative Strength Index (RSI) 64.63 52.53
Support Level $19.40 $7.85
Resistance Level $29.05 $15.06
Average True Range (ATR) 1.86 0.53
MACD 0.53 -0.06
Stochastic Oscillator 78.73 24.84

Price Performance

Historical Comparison
NGNE
SHIP

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through a modern fleet of Capesize vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.

Share on Social Networks: